Alpha Emitter Market with COVID-19 Impact Analysis, By Type of Radionuclide (Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, Others), By Application (Bone Metastases, Prostate Cancer, Neuroendocrine Tumors, Ovarian Cancer, Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Alpha Emitter Market size was valued at USD 416.87 Million in 2022, expanding at a CAGR of 12.6% from 2023 to 2030.
Alpha Emitter medicines are used to treat the symptoms and problems of bronchiectasis, a chronic lung disorder characterized by bronchial tube enlargement and inflammation. These medications are intended to treat symptoms such as persistent cough, excessive mucus production, and recurring lung infections. Antibiotics are often administered drugs to treat or prevent infections, bronchodilators to expand airways, and mucolytics to thin and promote mucus removal. Treatment strategies are customized to specific patient requirements, with an emphasis on symptom management, infection avoidance, and increasing total lung function to improve bronchiectasis patients\' quality of life.
Alpha Emitter Market- Market Dynamics
- Rising awareness of this often-underdiagnosed condition propel market demand
More instances of bronchiectasis are being detected as medical understanding and diagnostic technologies improve. Furthermore, an ageing population and a rise in chronic respiratory disorders raise the need for effective therapies. Because of the increased awareness and patient population, pharmaceutical firms and researchers are investing in the development of improved bronchiectasis care options, including innovative drugs. A important impetus is the desire to enhance the quality of life for bronchiectasis patients and minimize the burden of recurring infections and symptoms.
Alpha Emitter Market- Key Insights
- As per the analysis shared by our research analyst, the global Alpha Emitter market is estimated to grow annually at a CAGR of around 12.6% over the forecast period (2023-2030)
- The Alpha Emitter industry is projected to grow at a significant rate due to rising awareness of this often-underdiagnosed condition.
- Based on Type of Radionuclide segmentation, Radium (Ra-223) was predicted to show maximum market share in the year 2022
- Based on Application segmentation, Bone Metastases was the leading Type of Radionuclide in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Alpha Emitter Market- Segmentation Analysis:
The Global Alpha Emitter Market is segmented on the basis of Type of Radionuclide, Application, End User, and Region.
The market is divided into six categories based on Type of Radionuclide: Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, Others. The Radium (Ra-223) dominates the market. Radium-223 (Ra-223) is a radionuclide in high demand for targeted alpha-particle cancer treatment, particularly for metastatic prostate cancer. Its ability to specifically target malignant bone tissue while protecting good cells in the surrounding area makes it useful in improving the quality of life and survival rates for patients with severe prostate cancer that has gone to the bones.
The market is divided into five categories based on Application: Bone Metastases, Prostate Cancer, Neuroendocrine Tumors, Ovarian Cancer, Others. The Bone Metastases sector dominates the market and is likely to maintain its dominance during the forecast period. Alpha emitters are in high demand for treating bone metastases. Localized delivery of alpha particles to diseased bone tissue provides a successful treatment for relieving pain, inhibiting tumor development, and improving overall quality of life in patients with bone metastases, which are often linked with advanced malignancies such as prostate and breast cancer.
Alpha Emitter Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Alpha emitters are in high demand in North America due to their use in cancer therapy and nuclear medicine. These alpha-emitting isotopes are employed in targeted alpha-particle radiation, a novel method to cancer treatment that shows promise in the treatment of a variety of cancers. The region\'s ageing population and rising cancer incidence have increased need for more effective and accurate medicines. Furthermore, current research and clinical studies investigating the potential of alpha emitters in cancer therapy continue to fuel interest and demand in North America, as healthcare professionals strive to give improved and personalized treatment choices to their patients.
Alpha Emitter Market- Competitive Landscape:
The competitive environment for alpha emitters includes numerous significant firms in nuclear medicine and radiopharmaceuticals. Actinium Pharmaceuticals, Curium, and Lantheus Holdings are among the established firms actively involved in the research and manufacture of alpha-emitting isotopes for medicinal uses. Startups and research institutes are also helping to shape the competitive landscape by developing innovative alpha-emitter-based medicines and diagnostics. Collaborations with academic institutions and clinical studies are defining the landscape for the use of alpha emitters in targeted cancer treatment. As the need for precise and efficient cancer therapies rises, so does competition in this specialized field.
Recent Developments:
- In June 2023, Artbio, a start-up focused on producing radiopharmaceuticals to treat cancer, derives its name from one of its products: alpha radioligand treatments (ART). The Norwegian-based startup made its debut on June 21 with a USD 23 million initial round. Its therapeutic candidates include the -particle-emitting isotope-212Pb, which is linked to a cancer-targeting ligand.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ALPHA EMITTER MARKET KEY PLAYERS
- Actinium Pharmaceutical Inc.
- Alpha Tau Medical Ltd
- Bayer AG
- Bracco
- Cardinal Health
- Eckert & Ziegle
- Fusion Pharmaceuticals
- IBA Worldwide
- NorthStar Medical Radioisotopes (NMR)
- Orano Group
- Viewpoint Molecular Targeting
- RadioMedix
- Telix Pharmaceuticals Limited.
- TerraPower, LLC
- NIOWAVE Inc.
- IONETIX Corporation
GLOBAL ALPHA EMITTER MARKET, BY TYPE OF RADIONUCLIDE
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
GLOBAL ALPHA EMITTER MARKET, BY APPLICATION
- Bone Metastases
- Prostate Cancer
- Neuroendocrine Tumors
- Ovarian Cancer
- Others
GLOBAL ALPHA EMITTER MARKET, BY END USER
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Others
GLOBAL ALPHA EMITTER MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Alpha Emitter Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Alpha Emitter Market Snippet by Type of Radionuclide
2.1.2. Alpha Emitter Market Snippet by Application
2.1.3. Alpha Emitter Market Snippet by End User
2.1.4. Alpha Emitter Market Snippet by Country
2.1.5. Alpha Emitter Market Snippet by Region
2.2. Competitive Insights
3. Alpha Emitter Key Market Trends
3.1. Alpha Emitter Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Alpha Emitter Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Alpha Emitter Market Opportunities
3.4. Alpha Emitter Market Future Trends
4. Alpha Emitter Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Alpha Emitter Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Alpha Emitter Market Landscape
6.1. Alpha Emitter Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Alpha Emitter Market – By Type of Radionuclide
7.1. Overview
7.1.1. Segment Share Analysis, By Type of Radionuclide, 2022 & 2030 (%)
7.1.2. Radium (Ra-223)
7.1.3. Actinium (Ac-225)
7.1.4. Lead (Pb-212)
7.1.5. Astatine-211
7.1.6. Bismuth-213
7.1.7. Others
8. Alpha Emitter Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Bone Metastases
8.1.3. Prostate Cancer
8.1.4. Neuroendocrine Tumors
8.1.5. Ovarian Cancer
8.1.6. Others
9. Alpha Emitter Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
9.1.2. Hospitals
9.1.3. Specialty Clinics
9.1.4. Diagnostic Centers
9.1.5. Others
10. Alpha Emitter Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Alpha Emitter Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Alpha Emitter Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Alpha Emitter Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Alpha Emitter Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Alpha Emitter Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Alpha Emitter Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Actinium Pharmaceutical Inc.
11.2.2. Alpha Tau Medical Ltd
11.2.3. Bayer AG
11.2.4. Bracco
11.2.5. Cardinal Health
11.2.6. Eckert & Ziegle
11.2.7. Fusion Pharmaceuticals
11.2.8. IBA Worldwide
11.2.9. NorthStar Medical Radioisotopes (NMR)
11.2.10. Orano Group
11.2.11. Viewpoint Molecular Targeting
11.2.12. RadioMedix
11.2.13. Telix Pharmaceuticals Limited.
11.2.14. TerraPower, LLC
11.2.15. NIOWAVE Inc.
11.2.16. IONETIX Corporation.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
